# Structural and functional brain asymmetry in relation to heterogeneous causes of situs inversus totalis

**Authors:** Meng-Yun Wang, Nicole Ying Ting Ng, Else Eising, Simon E. Fisher, Guy Vingerhoets, Clyde Francks

PMC · DOI: 10.1007/s00429-026-03098-5 · Brain Structure & Function · 2026-03-13

## TL;DR

This study explores brain asymmetry in people with situs inversus totalis, a condition where internal organs are mirrored, and finds that brain structure is often reversed but brain function remains largely unchanged.

## Contribution

The study is the first to compare brain asymmetries in genetically explained and unexplained cases of situs inversus totalis using genome sequencing and brain imaging.

## Key findings

- Structural brain asymmetries like petalia and posterior venous anatomy are often reversed in situs inversus totalis cases.
- Functional brain asymmetries, such as language dominance, remain largely unaffected regardless of genetic causes.
- Brain structure changes in situs inversus totalis occur regardless of whether genetic causes are identified.

## Abstract

Various aspects of brain organization differ between the left and right hemispheres. Clues to the developmental origins of these asymmetries may be gained through associations with situs inversus totalis (SIT), a rare condition in which visceral organs are reversed on the left-right axis. In the largest previous brain imaging analyses of SIT (38 cases, 38 controls from Belgium), typical functional asymmetries such as left-hemisphere language dominance were mostly unaltered, but various aspects of asymmetrical cerebral structure - petalia, bending, and posterior venous anatomy—were often reversed in this condition. SIT can be a monogenic trait that arises from rare genetic variants, usually affecting motile cilia which help to create the embryonic left-right body axis. However, most SIT cases do not have obvious genetic causes and may arise from environmental or random effects during embryogenesis. We sequenced the genomes of 23 SIT cases and 23 controls from the Belgian brain imaging dataset and pooled with prior data from 15 cases and 15 controls. We aimed to discover whether there are altered brain asymmetries in SIT cases with disruptive DNA variants in ciliary genes, or in other types of genes, as compared to genetically unsolved cases. In total, 19 cases had likely causal variants affecting ciliary function, while 19 cases remained genetically unsolved. Functional and structural brain asymmetries were not significantly different in genetically solved versus unsolved SIT cases. Therefore, functional brain asymmetries seem largely independent of known mechanisms of visceral situs formation, while structural brain torque is altered in SIT regardless of the presence or absence of overt genetic causes.

The online version contains supplementary material available at 10.1007/s00429-026-03098-5.

## Linked entities

- **Diseases:** situs inversus totalis (MONDO:0010029)

## Full-text entities

- **Genes:** DNAH11 (dynein axonemal heavy chain 11) [NCBI Gene 8701] {aka CILD7, DNAHBL, DNAHC11, DNHBL, DPL11}, MYH7B (myosin heavy chain 7B) [NCBI Gene 57644] {aka MHC14, MYH14, lncMYH7b}, KIF13B (kinesin family member 13B) [NCBI Gene 23303] {aka GAKIN}, NODAL (nodal growth differentiation factor) [NCBI Gene 4838] {aka HTX5}, DCTN1 (dynactin subunit 1) [NCBI Gene 1639] {aka DAP-150, DP-150, HMND14, P135}, ODAD3 (outer dynein arm docking complex subunit 3) [NCBI Gene 115948] {aka CCDC151, CILD30, ODA10}, CFAP52 (cilia and flagella associated protein 52) [NCBI Gene 146845] {aka HTX10, WDR16, WDRPUH}, MYH1 (myosin heavy chain 1) [NCBI Gene 4619] {aka HEL71, MYHSA1, MYHa, MyHC-2X/D, MyHC-2x}, NCOA3 (nuclear receptor coactivator 3) [NCBI Gene 8202] {aka ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B}, CFAP77 (cilia and flagella associated protein 77) [NCBI Gene 389799] {aka C9orf171}, FOXJ1 (forkhead box J1) [NCBI Gene 2302] {aka CILD43, FKHL13, HFH-4, HFH4}, RIMS2 (regulating synaptic membrane exocytosis 2) [NCBI Gene 9699] {aka CRSDS, OBOE, RAB3IP3, RIM2}, UMODL1 (uromodulin like 1) [NCBI Gene 89766], EML6 (EMAP like 6) [NCBI Gene 400954], RP1L1 (RP1 like 1) [NCBI Gene 94137] {aka DCDC4B, OCMD, RP88}, DNAAF11 (dynein axonemal assembly factor 11) [NCBI Gene 23639] {aka CILD19, LRRC6, LRTP, TSLRP, tilB}, MYO7B (myosin VIIB) [NCBI Gene 4648], DNAAF4 (dynein axonemal assembly factor 4) [NCBI Gene 161582] {aka CILD25, DYX1, DYX1C1, DYXC1, EKN1, RD}, NME7 (NME/NM23 family member 7) [NCBI Gene 29922] {aka CFAP67, MN23H7, NDK 7, NDK7, nm23-H7}, CCDC66 (coiled-coil domain containing 66) [NCBI Gene 285331], MEGF8 (multiple EGF like domains 8) [NCBI Gene 1954] {aka C19orf49, CRPT2, EGFL4, SBP1}, ODAD1 (outer dynein arm docking complex subunit 1) [NCBI Gene 93233] {aka CCDC114, CILD20}, PCSK5 (proprotein convertase subtilisin/kexin type 5) [NCBI Gene 5125] {aka PC5, PC6, PC6A, SPC6}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, DNAH6 (dynein axonemal heavy chain 6) [NCBI Gene 1768] {aka DNHL1, Dnahc6, HL-2, HL2}, DNAH9 (dynein axonemal heavy chain 9) [NCBI Gene 1770] {aka CILD40, DNAH17L, DNEL1, DYH9, Dnahc9, HL-20}, CLIP2 (CAP-Gly domain containing linker protein 2) [NCBI Gene 7461] {aka CLIP, CLIP-115, CYLN2, WBSCR3, WBSCR4, WSCR3}, PKD1L1 (polycystin 1 like 1, transient receptor potential channel interacting) [NCBI Gene 168507] {aka HTX8, PRO19563}, KATNAL2 (katanin catalytic subunit A1 like 2) [NCBI Gene 83473], DNAH5 (dynein axonemal heavy chain 5) [NCBI Gene 1767] {aka CILD3, DNAHC5, HL1, KTGNR, PCD}, DNAH8 (dynein axonemal heavy chain 8) [NCBI Gene 1769] {aka ATPase, SPGF46, hdhc9}, DNAAF1 (dynein axonemal assembly factor 1) [NCBI Gene 123872] {aka CILD13, DAU1, LRRC50, ODA7, swt}
- **Diseases:** gastric (MESH:D013272), sinusitis (MESH:D012852), migraine (MESH:D008881), developmental syndrome (MESH:C562695), disrupted visceral laterality (MESH:D019958), deafness (MESH:D003638), obesity (MESH:D009765), VACTERL (MESH:C536495), depression (MESH:D003866), asymmetries (MESH:D005146), heterotaxia (MESH:C538116), cardiac malformations (MESH:D006331), polysyndactyly of the hands and feet (MESH:D013576), CF (MESH:D003550), situs abnormalities (MESH:D002278), laterality defects (MESH:C563391), essential tremor (MESH:D020329), respiratory infections (MESH:D012141), impaired movement of cilia (MESH:C536287), white matter asymmetries (MESH:D056784), PCD (MESH:D002925), developmental disorder (MESH:D002658), radial or renal dysplasia (MESH:C537580), dyslexia (MESH:D004410), cryptorchidism (MESH:D003456), craniosynostosis (MESH:D003398), I (MESH:D006969), deficits in mucus clearance (MESH:C565366), umbilical hernia (MESH:D006554), OMIM (MESH:D030342), multiple congenital malformation disorder (MESH:D000013), ADHD (MESH:D001289), Kartagener (MESH:D007619), dextrocardia (MESH:D003914), autosomal dominant non-syndromic congenital heart disease (MESH:D006330), cardiac abnormalities (MESH:D018376), Adams-Oliver syndrome 5 (MESH:C538225), situs ambiguous (MESH:D012734), SIT (MESH:D012857), bronchiectasis (MESH:D001987), fatigue (MESH:D005221), sporadic congenital disorder (MESH:C537592), esophageal atresia (MESH:D004933), transverse sinus asymmetry (MESH:D020227), CRPT2 (MESH:C563187), anorexia (MESH:D000855), neuropsychiatric disorders (MESH:D001523), laterality disorders (MESH:D000067562), airways (MESH:D000402), neurological (MESH:D009461), limb anomalies (MESH:C537769), heterotaxy (MESH:D059446), scalp and limb defects (MESH:D004476), anal atresia (MESH:D001006), vertebral defects (MESH:C535781), II (MESH:C537730)
- **Chemicals:** calcium (MESH:D002118)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031]
- **Mutations:** c.1213_1215del, c.7453T > C, rs1305797678, p.(Asp682Asn), rs765121016, c.2158G > T, Tyr1475Ter, c.11968-1G > C, p.E1394K, Leu2093His, His63Gln, c.G4180A, c.4546 C > A, c.2212 C > T, Gln1516Lys, rs932286708, Ala3823Val, rs779517512, p.(Phe166_Asp167insArg), Arg3539His, p.(Glu405del), rs528302390, c.8818 A > T, c.11468 C > T, rs548521732, rs779459076, c.10815del, p.S3939G, c.9637del, c.13381 C > T, p.(Ser216Ter), c.765 C > G, c.308del, c.4719T > G, Thr1897Met, c.1528 + 2 T > C, A11815G, Lys2940Ter, c.6473+2_6473 + 3del, c.10 + 1G > A, c.498_499insCGT, rs199574130, rs397515540, c.6278T > A, c.4360 C > T, p.(Arg399Ter), rs147133204, Arg4461Cys, c.10616G > A, rs1783569129, rs769795916, c.7421G > A
- **Cell lines:** NM_001370.2 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TD16)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987916/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12987916/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987916/full.md

---
Source: https://tomesphere.com/paper/PMC12987916